SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001427570-19-000043
Filing Date
2019-05-28
Accepted
2019-05-28 17:22:02
Documents
6
Period of Report
2019-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K obalon-8xkregistereddirect.htm 8-K 42457
2 EXHIBIT 5.1 obalon-exhibit51opinionlat.htm EX-5.1 11346
3 EXHIBIT 10.1 obln-spamay2019.htm EX-10.1 208404
4 EXHIBIT 99.1 obln-pricingprfinal52319.htm EX-99.1 8980
5 ex51lathamconsentheader.jpg GRAPHIC 31440
6 obalonexhibit51opinio_image1.gif GRAPHIC 13565
  Complete submission text file 0001427570-19-000043.txt   329250
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 19858731
SIC: 3841 Surgical & Medical Instruments & Apparatus